Unjha Formulations Ltd
Unjha Formulations Ltd (UNJHAFOR) last traded at ₹25.1, a market capitalisation of ₹11.2 crore, on a P/E of 23.4. Over the past 52 weeks the stock has ranged between ₹17.5 and ₹29.5. Unjha Formulations Ltd last reported results for the quarter ended Jun 2026, with sales of ₹3.31 crore and net profit of ₹0.16 crore. Figures are as of 25 Aug 2026 and are not real time.
Unjha Formulations Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Unjha Formulations Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹3.31 cr, down 8.8% from ₹3.63 cr a year earlier. Net profit was ₹0.16 cr, down 59.0% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 3.78 | 3.76 | 2.44 | 3.63 | 4.29 | 4.44 | 3.33 | 3.31 |
| Expenses | 3.89 | 3.52 | 2.7 | 3.21 | 3.5 | 4.16 | 3.78 | 3.12 |
| Operating profit | -0.11 | 0.24 | -0.26 | 0.42 | 0.79 | 0.28 | -0.45 | 0.19 |
| OPM % | -2.91% | 6.38% | -10.66% | 11.57% | 18.41% | 6.31% | -13.51% | 5.74% |
| Other income | 0.02 | 0.01 | 0 | 0 | 0.06 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 |
| Profit before tax | -0.11 | 0.23 | -0.29 | 0.39 | 0.82 | 0.24 | -0.49 | 0.15 |
| Tax % | 0.00% | 0.00% | 41.38% | 0.00% | 0.00% | 0.00% | 51.02% | 0.00% |
| Net profit | -0.11 | 0.22 | -0.41 | 0.39 | 0.82 | 0.24 | -0.74 | 0.16 |
| EPS (₹) | -0.25 | 0.49 | -0.92 | 0.87 | 1.83 | 0.54 | -1.65 | 0.36 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Unjha Formulations Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 9.96 | 14.16 | 13.15 | 18.5 | 13.86 | 15.59 | 15.37 |
| Operating profit | 0.13 | 0.32 | 0.44 | 0.57 | 0.52 | 0.95 | 0.81 |
| OPM % | 1.31% | 2.26% | 3.35% | 3.08% | 3.75% | 6.09% | 5.27% |
| Net profit | 0.1 | 0.25 | 0.28 | 0.28 | 0.41 | 0.7 | 0.48 |
| EPS (₹) | 0.22 | 0.56 | 0.62 | 0.62 | 0.92 | 1.56 | 1.08 |
TTM is the trailing twelve months to the most recent quarter.
Unjha Formulations Ltd growth and returns
- 10 Years
- 4%
- 5 Years
- 9%
- 3 Years
- 6%
- TTM
- 13%
- 10 Years
- 10%
- 5 Years
- 48%
- 3 Years
- 36%
- TTM
- 433%
- 10 Years
- 10%
- 5 Years
- 21%
- 3 Years
- 23%
- 1 Year
- 0%
- 10 Years
- 16%
- 5 Years
- 14%
- 3 Years
- 15%
- Last Year
- 20%
Unjha Formulations Ltd shareholding pattern
Promoters held 36.92% at Jun 2026, broadly unchanged since Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 36.92% | 36.92% | 36.92% | 36.92% | 36.92% | 36.92% | 36.92% | 36.92% |
| Public | 63.07% | 63.07% | 63.07% | 63.08% | 63.08% | 63.08% | 63.08% | 63.07% |
| No. of shareholders | 3,969 | 4,208 | 4,273 | 4,213 | 4,284 | 4,251 | 4,235 | 4,223 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Unjha Formulations Ltd corporate filings
- REGULATION 44(3) OF SEBI(LODR) REGULATION ,2015 / SCRUTINIZER REPORTAGM/EGMlow impact
Cruxal's analysis: Unjha Formulations Limited has disclosed the voting results for its 32nd Annual General…
Read the full analysis - Filing Of Distribution ScheduleCompany Updatelow impact
Cruxal's analysis: Unjha Formulations Ltd has submitted its distribution schedule in compliance with SEBI…
Read the full analysis - Cash Flow Statement for the year ended 31.03.2026Company Updatelow impact
Cruxal's analysis: Unjha Formulations Ltd has filed its Cash Flow Statement for the financial year ended…
Read the full analysis - Cash Flow Statement for the year ended 31.03.2026Company Updatelow impact
Cruxal's analysis: Unjha Formulations Ltd has filed its Cash Flow Statement for the financial year ended…
Read the full analysis - REGULATION 30 OF THE SEBI (LODR) 2015, OUTCOME OF AGM HELD ON 14-08-2026AGM/EGMlow impact
Cruxal's analysis: Unjha Formulations Limited has successfully concluded its 32nd Annual General Meeting…
Read the full analysis - REG 33 (3) OF SEBI (LODR) ACT 2015Company Updatehigh impact
Cruxal's analysis: Unjha Formulations Limited reported a decline in performance for the quarter ended 30…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Unjha Formulations Ltd
Cruxal reads every Unjha Formulations Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.